InvestorsHub Logo
Followers 47
Posts 12038
Boards Moderated 0
Alias Born 09/12/2017

Re: justdafactss post# 229885

Thursday, 02/22/2024 9:08:02 PM

Thursday, February 22, 2024 9:08:02 PM

Post# of 232961
UH OH--- In late January 2024, the Company made its responsive submission to the FDA’s December 2023 comments and guidance in relation to its proposed clinical trial protocol. The Company anticipates moving forward with the contemplated clinical trial during the 2024 calendar year in the event that its efforts to obtain lifting of the clinical hold are successful.
https://www.sec.gov/Archives/edgar/data/1175680/000155837024001547/cydy-20240130x424b3.htm

I could be wrong, but it looks as if the late January 2024 responsive submission to the FDA’s December 2023 comments and guidance has been denied.

3 weeks after the late January 2024 submission and co hold is un-successful.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News